Aspa Therapeutics is working to develop a safe and effective gene therapy for patients with Canavan disease, a rare condition caused by an inherited mutation of the ASPA gene.
| Website | https://aspatx.com |
| Employees | 3 (3 on RocketReach) |
| Address | 3160 Porter Dr Suite 250, Palo Alto, California 94304, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Gene Therapy, Rare Disease Treatment, Genetic Disease Treatment, Advanced Therapy Medicinal Products, Enzyme Replacement Therapy, Genetic Engineering, Biotechnology, Pharmaceutical Research, Drug Development, Genetic Medicine, Rare Disease Research |
| Competitors | Amgen, Gilead Sciences, Novartis, Regeneron, Biogen, Vertex Pharmaceuticals, AstraZeneca, Sanofi, AbbVie, Bristol Myers Squibb +41 more (view full list) |
Looking for a particular Aspa Therapeutics employee's phone or email?
3 people are employed at Aspa Therapeutics.
Aspa Therapeutics is based in Palo Alto, California.